Suppr超能文献

白细胞端粒长度与消化系统疾病风险的关联:一项大规模队列研究。

Association of leukocyte telomere length with the risk of digestive diseases: A large-scale cohort study.

作者信息

Yang Hongqun, Chen Lanlan, Liu Yahui

机构信息

The Secondary Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, First Hospital of Jilin University, Changchun, Jilin 130021, China.

The First Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, First Hospital of Jilin University, Changchun, Jilin 130021, China.

出版信息

Chin Med J (Engl). 2025 Jan 5;138(1):60-67. doi: 10.1097/CM9.0000000000002994. Epub 2024 Dec 6.

Abstract

BACKGROUND

Leukocyte telomere length (LTL) shortening, a biomarker of telomere attrition, has been linked to multiple diseases. However, the relationship between LTL and digestive diseases remains uncertain. This study aimed to investigate the association between LTL and the risk of digestive diseases.

METHODS

A cohort analysis of over 500,000 participants from the UK Biobank (UKB) between 2006 and 2021 was conducted to estimate the associations of LTL with more than 90 common digestive diseases. LTL was quantified using multiplex quantitative polymerase chain reaction, and cases of each disease were determined according to inpatient and primary care data. Multivariable Cox proportional hazards regression analysis was used to evaluate the associations of LTL with the risk of digestive diseases. Furthermore, such associations were also evaluated after stratification by sex and ethnicity.

RESULTS

After a mean follow-up time of 11.8 years, over 20 International Classification of Diseases, 10th Revision ( ICD-10 ) codes were showed to be associated with telomere attrition. LTL shortening is associated with an increased risk of several digestive diseases, including gastroesophageal reflux disease (K21: hazard ratio [HR] = 1.30, 95% confidence interval [95% CI]: 1.19-1.42), esophageal ulcer (K221: HR = 1.81, 95% CI: 1.22-2.71), Barrett's esophagus (K227: HR = 1.58, 95% CI: 1.14-2.17), gastritis (K29: HR = 1.39, 95% CI: 1.26-1.52), duodenal ulcer (K26: HR = 1.55, 95% CI: 1.14-2.12), functional dyspepsia (K30X: HR = 1.36, 95% CI: 1.06-1.69), non-alcoholic fatty liver disease (NAFLD) (K760: HR = 1.39, 95% CI: 1.09-1.78), liver cirrhosis (K74: HR = 4.73, 95% CI: 3.27-6.85), cholangitis (K830: HR = 2.55, 95% CI: 1.30-5.00), and hernia (K43: HR = 1.50, 95% CI: 1.17-1.94; K44: HR = 1.29, 95% CI: 1.17-1.42). The risk of rectal polyps (K621: HR = 0.77, 95% CI: 0.63-0.92) decreased per unit shortening of LTL.

CONCLUSIONS

This study suggests that LTL shortening is associated with an increased risk of most digestive diseases except for rectal polyps. These findings may provide some clues for understanding the pathogenesis of digestive diseases.

摘要

背景

白细胞端粒长度(LTL)缩短是端粒磨损的生物标志物,与多种疾病有关。然而,LTL与消化系统疾病之间的关系仍不确定。本研究旨在探讨LTL与消化系统疾病风险之间的关联。

方法

对英国生物银行(UKB)2006年至2021年间超过50万名参与者进行队列分析,以评估LTL与90多种常见消化系统疾病的关联。使用多重定量聚合酶链反应对LTL进行量化,并根据住院和初级保健数据确定每种疾病的病例。采用多变量Cox比例风险回归分析来评估LTL与消化系统疾病风险的关联。此外,还按性别和种族进行分层后评估此类关联。

结果

平均随访11.8年后,超过20个国际疾病分类第十版(ICD-10)编码显示与端粒磨损有关。LTL缩短与几种消化系统疾病风险增加有关,包括胃食管反流病(K21:风险比[HR]=1.30,95%置信区间[95%CI]:1.19-1.42)、食管溃疡(K221:HR=1.81,95%CI:1.22-2.71)、巴雷特食管(K227:HR=1.58,95%CI:1.14-2.17)、胃炎(K29:HR=1.39,95%CI:1.26-1.52)、十二指肠溃疡(K26:HR=1.55,95%CI:1.14-2.12)、功能性消化不良(K30X:HR=1.36,95%CI:1.06-1.69)、非酒精性脂肪性肝病(NAFLD)(K760:HR=1.39,95%CI:1.09-1.78)、肝硬化(K74:HR=4.73,95%CI:3.27-6.85)、胆管炎(K830:HR=2.55,95%CI:1.30-5.00)和疝气(K43:HR=1.50,95%CI:1.17-1.94;K44:HR=1.29,95%CI:1.17-1.42)。LTL每缩短一个单位,直肠息肉(K621:HR=0.77,95%CI:0.63-0.92)的风险降低。

结论

本研究表明,LTL缩短与除直肠息肉外的大多数消化系统疾病风险增加有关。这些发现可能为理解消化系统疾病的发病机制提供一些线索。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb6d/11717523/0346e6ae5082/cm9-138-060-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验